Temozolomide-induced vitiligo-like reaction: An extremely rare phenomenon.
| Autor: | Madan R; Department of Radiotherapy and Oncology, PGIMER, Chandigarh, India., Raja MK; Department of Radiotherapy and Oncology, PGIMER, Chandigarh, India., Mahajan R; Department of Dermatology, PGIMER, Chandigarh, India., Goyal S; Department of Radiotherapy and Oncology, PGIMER, Chandigarh, India. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Jan 01; Vol. 19 (Suppl 2), pp. S896-S897. Date of Electronic Publication: 2023 Apr 27. |
| DOI: | 10.4103/jcrt.jcrt_2037_21 |
| Abstrakt: | Abstract: Temozolomide (TMZ) is an alkylating chemotherapeutic drug, often used in high-grade glioma and metastatic melanoma. Common side effects of this include myelosuppression and gastrointestinal side effects. Vitiligo-like reaction is extremely rare after TMZ. Here, we report a case of a 55-year-old patient of glioblastoma who developed vitiligo-like reaction after starting adjuvant TMZ. (Copyright © 2023 Copyright: © 2023 Journal of Cancer Research and Therapeutics.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|